Evans, David A.2017-05-222017-05-221996https://hdl.handle.net/1813/49839After technical, regulatory, and consumer acceptance there is an additional major hurdle in biotechnology development: intellectual property. For some technologies and genes, patents have been issued and represent barriers to commercialization. For other patents are still pending and represent an uncertainty. Patents are being aggressively enforced and used to establish competitive advantage in the marketplace. However, the modification of consumer-preferences traits could have implications beyond the simple gene insertion: cultivation, post-harvest treatment, packing, and shipping.en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalAgricultural biotechnologygenetic engineering, recombinant DNAfeed industryenergy industryconsumer sentimentpopulation growthenvironmental impactsbioremediationrisk assessmentregulationglobal market systembook chapter